SlideShare a Scribd company logo
1 of 15
PRESENTED BY : Nisha N
Dept . Of Pharmaceutics
1)History of Helsinki
2)Introduction
3)Basic principle of all Medical Research
4)Additional principles for medical research
combined with medical care
1. The Declaration was originally adopted in June 1964 in Helsinki, Finland, and has
since undergone seven revisions (the most recent at the General Assembly in
October 2013) and two clarifications, growing considerably in length from 11
paragraphs in 1964 to 37 in the 2013 version.
2. The Declaration is an important document in the history of research ethics as in
is the first significant effort of the medical community to regulate research itself
3. Prior to the 1947 Nuremberg Code there was no generally accepted code of
conduct governing the ethical aspects of human research, although some
countries, notably German and Russia, had national policies
4. The Declaration developed the ten principles first stated in the Nuremberg Code,
and tied them to the Declaration of Geneva (1948), statement of physicians'
ethical duties.
5. The Declaration more specifically addressed clinical research, reflecting changes
in medical practice from the term 'Human Experimentation use in the Nuremberg
Code.
FIRST REVISION (1975)
1. The 1975 revision was almost twice the length of the original.
2. It clearly stated that "concern for the interests of the subject must always prevail
over the interests of science and society. “
3. It also introduced the concept of oversight by an independent committee'
(Article 1.2) which became a system of Institutional Review Boards (IRB) in the
US, and research ethics committees or ethical review boards in other countries.
4. In the United States regulations governing IRBs came into effect in 1981 and are
now encapsulated in the Common Rule.
SECOND TO FOURTH REVISIONS (1975-2000)
Subsequent revisions between 1975 and 2000 were relatively minor, so the 1975
version was effectively that which governed research over a quarter of a century of
relative stability.
SECOND AND THIRD REVISIONS (1983, 1989)
1. The second revision (1983) included seeking the consent of minors
where possible.
2. The third revision (1989) dealt further with the function and structure of the
independent committee.
3. However, from 1993 onwards, the Declaration was not alone as a universal
guide since CIOMS and the World Health Organization (WHO) had also
developed their International Ethical Guidelines for Biomedical Research
Involving Human Subjects.
FOURTH REVISION (1996)
1. The AIDS Clinical Trials Group (ACTG) Study 076 of 100 Zidovudine in maternal-
infant transmission of HIV had been published in 1994.
2. This was a placebo controlled trial which showed a reduction
of nearly 70% in the risk of transmission, and Zidovudine
became a de facto standard of care.
3. The subsequent initiation of further placebo controlled trials carried out
in developing countries and funded by the United States Centers for
Disease Control or National Institutes of Health raised considerable
concern when it was learned that patients in trials in the US had
essentially unrestricted access to the drug, while those in developing
countries did not.
4. Justification was provided by a 1994 WHO group in Geneva which
concluded "Placebo-controlled trials offer the best option for a rapid
and scientifically valid assessment of alternative antiretroviral drug
regimens to prevent transmission of HIV".
FIFTH REVISION (2000)
1. Following the fourth revision in 1996 pressure began to build
almost immediately for a morefundamental approach to revising
the declaration.
2. The later revision in 2000 would go on torequire monitoring of scientific
research on human subjects to assure ethical standards werebeing met.
3. In 1997 Lurie and Wolfe published their seminal paper on HIV trials, raising
awareness of a number of central issues.
4. The issue of the useof placebo in turn raised questions about the standard of
care in developing counties andwhether, as Marcia Angell wrote "Human
subjects in any part of the world should be protected by an irreducible set of
ethical standards" (1988).
5. These implications furthercame into public view since the Helsinki declaration
had stated, "In the treatment of the sickperson, the physician must be free to
use a new diagnostic and therapeutic measure, if in his or her judgement, it
offers hope of saving life, reestablishing health or alleviating suffering."
SIXTH REVISION (2008)
1. The sixth revision cycle commenced in May 2007.
2. This consisted of a call for submissions, completed in August 2007.
3. Further workshops were held in Cairo and São Paulo and the comments collated
in August 2008.
4. A final text was then developed by the Working Group for consideration by the
Ethics Committee and finally the General Assembly, which approved it on
October 18
SEVENTH REVISION (2013)
1. The most recent iteration of Helsinki (2013) was reflective of the controversy
regarding the standard of care that arose from the vertical transmission trials.
2. The revised declaration of 2013 also highlights the need to disseminate research
results, including negative and inconclusive studies and also includes a
requirement for treatment and compensation for injuries related to research
1. In 1964, the World Medical Association wrote the Declaration of Helsinki.
2. There were a set of ethical recommendation for human experimentation and
became the foundation of human research ethics .
3. The main points set out in this declaration were that animalexperimentation
should come before any human experimented on, there should always be a
review by an independent committee before the experiment , informed consent
is always necessary , only qualified people should carry out experiments .
4. It is the mission of the physician to safeguard the health of the people.
5. His or her knowledge and conscience are dedicated to the fulfilment of this
mission.
6. The purpose of biomedical research involving human subjects must be to
improve diagnostic, therapeutic and prophylactic procedures and the
understanding of the etiology and pathogenesis of disease.
7. In current medical practice most diagnostic, therapeutic or
prophylactic procedures involve hazards.
8. This applies especially to biomedical research. Special caution must be
exercised in the conduct of research which may affect the
environment, and the welfare of animals used for research must be
respected.
9. Because it is essential that the results of laboratory experiments be
applied to human beings to further scientific knowledge and to help
suffering humanity .
10. The World Medical Association has prepared the following
recommendations as a guide to every physician in biomedical research
involving human subjects.
11. They should be kept under review in the future.
12. Physicians are not relieved from criminal, civil and ethical
responsibilities under the law of their own countries.
biostatistics.pptx  research methodology
biostatistics.pptx  research methodology
biostatistics.pptx  research methodology
biostatistics.pptx  research methodology
biostatistics.pptx  research methodology

More Related Content

Similar to biostatistics.pptx research methodology

Introduction to research ethics
Introduction to research ethicsIntroduction to research ethics
Introduction to research ethics
Tamer Hifnawy
 
Ethical Concerns Regarding Research on Human Subjects
Ethical Concerns Regarding Research on Human SubjectsEthical Concerns Regarding Research on Human Subjects
Ethical Concerns Regarding Research on Human Subjects
ClinosolIndia
 
Ethical Issues in Medical Research_12 Jan 2017_Fortis Mulund.ppt
Ethical Issues in Medical Research_12 Jan 2017_Fortis Mulund.pptEthical Issues in Medical Research_12 Jan 2017_Fortis Mulund.ppt
Ethical Issues in Medical Research_12 Jan 2017_Fortis Mulund.ppt
RitaLakhani2
 

Similar to biostatistics.pptx research methodology (20)

The declaration of helsinki by akshdeep sharma
The declaration of helsinki by akshdeep sharmaThe declaration of helsinki by akshdeep sharma
The declaration of helsinki by akshdeep sharma
 
Declaration of helsinki (Pharmacology SEM-III)
Declaration of helsinki (Pharmacology SEM-III)Declaration of helsinki (Pharmacology SEM-III)
Declaration of helsinki (Pharmacology SEM-III)
 
Acs presentation
Acs presentationAcs presentation
Acs presentation
 
Basics of Clinical Research.ppt
Basics of Clinical Research.pptBasics of Clinical Research.ppt
Basics of Clinical Research.ppt
 
Basics%20of%20Clinical%20Research%20(1).pptx
Basics%20of%20Clinical%20Research%20(1).pptxBasics%20of%20Clinical%20Research%20(1).pptx
Basics%20of%20Clinical%20Research%20(1).pptx
 
Ethics and nursing research
Ethics and nursing researchEthics and nursing research
Ethics and nursing research
 
Good clinical practices
Good clinical practicesGood clinical practices
Good clinical practices
 
Introduction to research ethics
Introduction to research ethicsIntroduction to research ethics
Introduction to research ethics
 
Lecture 18 research ethics (1)
Lecture 18 research ethics (1)Lecture 18 research ethics (1)
Lecture 18 research ethics (1)
 
GCP Refresher Training (Chcuk) V2
GCP Refresher Training (Chcuk) V2GCP Refresher Training (Chcuk) V2
GCP Refresher Training (Chcuk) V2
 
Declaration of helsinki powerpoint presentation
Declaration of helsinki powerpoint presentationDeclaration of helsinki powerpoint presentation
Declaration of helsinki powerpoint presentation
 
5.ethical consideration in research
5.ethical consideration in research5.ethical consideration in research
5.ethical consideration in research
 
International health
International healthInternational health
International health
 
Helsinki decleration
Helsinki declerationHelsinki decleration
Helsinki decleration
 
Gcp final
Gcp finalGcp final
Gcp final
 
9. Medical Research.pptx
9. Medical Research.pptx9. Medical Research.pptx
9. Medical Research.pptx
 
Ethical Concerns Regarding Research on Human Subjects
Ethical Concerns Regarding Research on Human SubjectsEthical Concerns Regarding Research on Human Subjects
Ethical Concerns Regarding Research on Human Subjects
 
Ethical Issues in Medical Research_12 Jan 2017_Fortis Mulund.ppt
Ethical Issues in Medical Research_12 Jan 2017_Fortis Mulund.pptEthical Issues in Medical Research_12 Jan 2017_Fortis Mulund.ppt
Ethical Issues in Medical Research_12 Jan 2017_Fortis Mulund.ppt
 
Declaration of Helsinki
Declaration of HelsinkiDeclaration of Helsinki
Declaration of Helsinki
 
Ethics of Medical Researches
Ethics of Medical ResearchesEthics of Medical Researches
Ethics of Medical Researches
 

More from GirijaSoori (7)

Medical ethics biostatistics and research
Medical ethics biostatistics and researchMedical ethics biostatistics and research
Medical ethics biostatistics and research
 
MP_Unit1_Class1_Introduction to targeted drug delivery system.pptx
MP_Unit1_Class1_Introduction to targeted drug delivery system.pptxMP_Unit1_Class1_Introduction to targeted drug delivery system.pptx
MP_Unit1_Class1_Introduction to targeted drug delivery system.pptx
 
absorption of drugs.ppt
absorption of drugs.pptabsorption of drugs.ppt
absorption of drugs.ppt
 
keerthy sir lesson 1.pptx
keerthy sir lesson 1.pptxkeerthy sir lesson 1.pptx
keerthy sir lesson 1.pptx
 
correlation of invivo data with invitro dissolution data.pptx
correlation of invivo data with invitro dissolution data.pptxcorrelation of invivo data with invitro dissolution data.pptx
correlation of invivo data with invitro dissolution data.pptx
 
Factors Affecting Drug Absorption {BRD}.pptx
Factors Affecting Drug Absorption {BRD}.pptxFactors Affecting Drug Absorption {BRD}.pptx
Factors Affecting Drug Absorption {BRD}.pptx
 
Modern pharmaceutics
Modern pharmaceutics Modern pharmaceutics
Modern pharmaceutics
 

Recently uploaded

Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
EADTU
 
MuleSoft Integration with AWS Textract | Calling AWS Textract API |AWS - Clou...
MuleSoft Integration with AWS Textract | Calling AWS Textract API |AWS - Clou...MuleSoft Integration with AWS Textract | Calling AWS Textract API |AWS - Clou...
MuleSoft Integration with AWS Textract | Calling AWS Textract API |AWS - Clou...
MysoreMuleSoftMeetup
 
Spellings Wk 4 and Wk 5 for Grade 4 at CAPS
Spellings Wk 4 and Wk 5 for Grade 4 at CAPSSpellings Wk 4 and Wk 5 for Grade 4 at CAPS
Spellings Wk 4 and Wk 5 for Grade 4 at CAPS
AnaAcapella
 

Recently uploaded (20)

Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptx
 
Observing-Correct-Grammar-in-Making-Definitions.pptx
Observing-Correct-Grammar-in-Making-Definitions.pptxObserving-Correct-Grammar-in-Making-Definitions.pptx
Observing-Correct-Grammar-in-Making-Definitions.pptx
 
dusjagr & nano talk on open tools for agriculture research and learning
dusjagr & nano talk on open tools for agriculture research and learningdusjagr & nano talk on open tools for agriculture research and learning
dusjagr & nano talk on open tools for agriculture research and learning
 
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdf
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdfFICTIONAL SALESMAN/SALESMAN SNSW 2024.pdf
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdf
 
Details on CBSE Compartment Exam.pptx1111
Details on CBSE Compartment Exam.pptx1111Details on CBSE Compartment Exam.pptx1111
Details on CBSE Compartment Exam.pptx1111
 
21st_Century_Skills_Framework_Final_Presentation_2.pptx
21st_Century_Skills_Framework_Final_Presentation_2.pptx21st_Century_Skills_Framework_Final_Presentation_2.pptx
21st_Century_Skills_Framework_Final_Presentation_2.pptx
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 
Play hard learn harder: The Serious Business of Play
Play hard learn harder:  The Serious Business of PlayPlay hard learn harder:  The Serious Business of Play
Play hard learn harder: The Serious Business of Play
 
OSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & SystemsOSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & Systems
 
How to Manage Call for Tendor in Odoo 17
How to Manage Call for Tendor in Odoo 17How to Manage Call for Tendor in Odoo 17
How to Manage Call for Tendor in Odoo 17
 
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
MuleSoft Integration with AWS Textract | Calling AWS Textract API |AWS - Clou...
MuleSoft Integration with AWS Textract | Calling AWS Textract API |AWS - Clou...MuleSoft Integration with AWS Textract | Calling AWS Textract API |AWS - Clou...
MuleSoft Integration with AWS Textract | Calling AWS Textract API |AWS - Clou...
 
Including Mental Health Support in Project Delivery, 14 May.pdf
Including Mental Health Support in Project Delivery, 14 May.pdfIncluding Mental Health Support in Project Delivery, 14 May.pdf
Including Mental Health Support in Project Delivery, 14 May.pdf
 
Spellings Wk 4 and Wk 5 for Grade 4 at CAPS
Spellings Wk 4 and Wk 5 for Grade 4 at CAPSSpellings Wk 4 and Wk 5 for Grade 4 at CAPS
Spellings Wk 4 and Wk 5 for Grade 4 at CAPS
 
When Quality Assurance Meets Innovation in Higher Education - Report launch w...
When Quality Assurance Meets Innovation in Higher Education - Report launch w...When Quality Assurance Meets Innovation in Higher Education - Report launch w...
When Quality Assurance Meets Innovation in Higher Education - Report launch w...
 
What is 3 Way Matching Process in Odoo 17.pptx
What is 3 Way Matching Process in Odoo 17.pptxWhat is 3 Way Matching Process in Odoo 17.pptx
What is 3 Way Matching Process in Odoo 17.pptx
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptxCOMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
 
Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)
 

biostatistics.pptx research methodology

  • 1. PRESENTED BY : Nisha N Dept . Of Pharmaceutics
  • 2. 1)History of Helsinki 2)Introduction 3)Basic principle of all Medical Research 4)Additional principles for medical research combined with medical care
  • 3. 1. The Declaration was originally adopted in June 1964 in Helsinki, Finland, and has since undergone seven revisions (the most recent at the General Assembly in October 2013) and two clarifications, growing considerably in length from 11 paragraphs in 1964 to 37 in the 2013 version. 2. The Declaration is an important document in the history of research ethics as in is the first significant effort of the medical community to regulate research itself 3. Prior to the 1947 Nuremberg Code there was no generally accepted code of conduct governing the ethical aspects of human research, although some countries, notably German and Russia, had national policies 4. The Declaration developed the ten principles first stated in the Nuremberg Code, and tied them to the Declaration of Geneva (1948), statement of physicians' ethical duties. 5. The Declaration more specifically addressed clinical research, reflecting changes in medical practice from the term 'Human Experimentation use in the Nuremberg Code.
  • 4. FIRST REVISION (1975) 1. The 1975 revision was almost twice the length of the original. 2. It clearly stated that "concern for the interests of the subject must always prevail over the interests of science and society. “ 3. It also introduced the concept of oversight by an independent committee' (Article 1.2) which became a system of Institutional Review Boards (IRB) in the US, and research ethics committees or ethical review boards in other countries. 4. In the United States regulations governing IRBs came into effect in 1981 and are now encapsulated in the Common Rule. SECOND TO FOURTH REVISIONS (1975-2000) Subsequent revisions between 1975 and 2000 were relatively minor, so the 1975 version was effectively that which governed research over a quarter of a century of relative stability.
  • 5. SECOND AND THIRD REVISIONS (1983, 1989) 1. The second revision (1983) included seeking the consent of minors where possible. 2. The third revision (1989) dealt further with the function and structure of the independent committee. 3. However, from 1993 onwards, the Declaration was not alone as a universal guide since CIOMS and the World Health Organization (WHO) had also developed their International Ethical Guidelines for Biomedical Research Involving Human Subjects. FOURTH REVISION (1996) 1. The AIDS Clinical Trials Group (ACTG) Study 076 of 100 Zidovudine in maternal- infant transmission of HIV had been published in 1994.
  • 6. 2. This was a placebo controlled trial which showed a reduction of nearly 70% in the risk of transmission, and Zidovudine became a de facto standard of care. 3. The subsequent initiation of further placebo controlled trials carried out in developing countries and funded by the United States Centers for Disease Control or National Institutes of Health raised considerable concern when it was learned that patients in trials in the US had essentially unrestricted access to the drug, while those in developing countries did not. 4. Justification was provided by a 1994 WHO group in Geneva which concluded "Placebo-controlled trials offer the best option for a rapid and scientifically valid assessment of alternative antiretroviral drug regimens to prevent transmission of HIV".
  • 7. FIFTH REVISION (2000) 1. Following the fourth revision in 1996 pressure began to build almost immediately for a morefundamental approach to revising the declaration. 2. The later revision in 2000 would go on torequire monitoring of scientific research on human subjects to assure ethical standards werebeing met. 3. In 1997 Lurie and Wolfe published their seminal paper on HIV trials, raising awareness of a number of central issues. 4. The issue of the useof placebo in turn raised questions about the standard of care in developing counties andwhether, as Marcia Angell wrote "Human subjects in any part of the world should be protected by an irreducible set of ethical standards" (1988). 5. These implications furthercame into public view since the Helsinki declaration had stated, "In the treatment of the sickperson, the physician must be free to use a new diagnostic and therapeutic measure, if in his or her judgement, it offers hope of saving life, reestablishing health or alleviating suffering."
  • 8. SIXTH REVISION (2008) 1. The sixth revision cycle commenced in May 2007. 2. This consisted of a call for submissions, completed in August 2007. 3. Further workshops were held in Cairo and São Paulo and the comments collated in August 2008. 4. A final text was then developed by the Working Group for consideration by the Ethics Committee and finally the General Assembly, which approved it on October 18 SEVENTH REVISION (2013) 1. The most recent iteration of Helsinki (2013) was reflective of the controversy regarding the standard of care that arose from the vertical transmission trials. 2. The revised declaration of 2013 also highlights the need to disseminate research results, including negative and inconclusive studies and also includes a requirement for treatment and compensation for injuries related to research
  • 9. 1. In 1964, the World Medical Association wrote the Declaration of Helsinki. 2. There were a set of ethical recommendation for human experimentation and became the foundation of human research ethics . 3. The main points set out in this declaration were that animalexperimentation should come before any human experimented on, there should always be a review by an independent committee before the experiment , informed consent is always necessary , only qualified people should carry out experiments . 4. It is the mission of the physician to safeguard the health of the people. 5. His or her knowledge and conscience are dedicated to the fulfilment of this mission. 6. The purpose of biomedical research involving human subjects must be to improve diagnostic, therapeutic and prophylactic procedures and the understanding of the etiology and pathogenesis of disease.
  • 10. 7. In current medical practice most diagnostic, therapeutic or prophylactic procedures involve hazards. 8. This applies especially to biomedical research. Special caution must be exercised in the conduct of research which may affect the environment, and the welfare of animals used for research must be respected. 9. Because it is essential that the results of laboratory experiments be applied to human beings to further scientific knowledge and to help suffering humanity . 10. The World Medical Association has prepared the following recommendations as a guide to every physician in biomedical research involving human subjects. 11. They should be kept under review in the future. 12. Physicians are not relieved from criminal, civil and ethical responsibilities under the law of their own countries.